A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B - 08/08/11
Summary |
Objective |
To compare the effectiveness of zanamivir with oseltamivir for influenza A and B.
Methods |
1113 patients with influenza A or B were enrolled in the 2006–2007 influenza season. The duration of fever (temperature, ≧37.5°C) and the percentage of patients afebrile at 24 and 48h after the first dose of zanamivir or oseltamivir were calculated. Virus persistence after zanamivir therapy was also evaluated.
Results |
There were marginally significant differences between the duration of fever after the first dose of zanamivir (31.8±18.4h) and oseltamivir (35.5±23.9h) for influenza A (p<0.05). The duration of fever after starting zanamivir therapy (35.8±22.4h) was significantly shorter than that of oseltamivir (52.7±31.3h) for influenza B (p<0.001). There were no significant differences between influenza A and B in the percentage of patients afebrile at 24 or 48h after the first inhalation of zanamivir. The reisolation rate after zanamivir therapy showed marginally significant differences between influenza A and B (<0.05). By multiple regression analysis, therapy (zanamivir or oseltamivir) was the major determinant affecting the duration of fever for influenza B.
Conclusion |
Zanamivir therapy is more effective than oseltamivir for the treatment of influenza B infection.
Le texte complet de cet article est disponible en PDF.Keywords : Influenza, Zanamivir, Oseltamivir, Virus isolation, Antigen detection test kits
Plan
Vol 56 - N° 1
P. 51-57 - janvier 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?